Company: USB-PA
Filing Date: 2025-03-25
Form Type: DEFA14A
Source: 0001193125-25-062564
Chunk: 0

Company: US BANCORP \DE\
Filing Date: 2025-03-25
Form: DEFA14A
Chunk 0
---
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box:

| ☐ | Preliminary Proxy Statement |

| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 
 14a-6(e)(2))                                                       |

| ☐ | Definitive Proxy Statement |

| ☒ | Definitive Additional Materials |

| ☐ | Soliciting Material under §240.14a-12 |

U.S. Bancorp (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box):

| ☒ | No fee required. |

| ☐ | Fee paid previously with preliminary materials. |

| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act rules 14a6(i)(1) and 0-11 |

Supplement to the Proxy Statement for the Annual Meeting of Shareholders of U.S. Bancorp to be held on April 15, 2025 This proxy statement supplement (the Supplement), dated March 25, 2025, provides updated information with respect to the 2025 annual meeting of shareholders (the Annual Meeting) of U.S. Bancorp (the Company) to be held on Tuesday, April 15, 2025, at 11:00 a.m., central time. This Supplement is being filed with the U.S. Securities and Exchange Commission and is being made available to the shareholders of the Company on or about March 25, 2025. Except as described in this Supplement, the information provided in the definitive proxy statement filed by the Company with the SEC on March 5, 2025 (as supplemented, the Proxy Statement), continues to apply. To the extent the information in this Supplement differs from or updates information in the Proxy Statement, our shareholders should rely on the information contained in this Supplement. You should read the entire Proxy Statement, this Supplement (which contains important information that supplements and updates the Proxy Statement), and any additional proxy materials carefully before voting your shares. Withdrawal of nominee for director As described in our Current Report on Form 8-Kfiled with the